-
Regulus Therapeutics' (RGLS) "Buy" Rating Reaffirmed at HC Wainwright
来源: Buzz FX / 15 3月 2025 08:16:17 America/New_York
Regulus Therapeutics' (RGLS) "Buy" Rating Reaffirmed at HC Wainwright Written by MarketBeat March 15, 2025 Share Link copied to clipboard. Remove Ads Regulus Therapeutics ( NASDAQ:RGLS - Get Free Report ) 's stock had its "buy" rating reiss
Read more...